CONMED Corp — Director's Dealing 2020

Dec 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-11-30

Reporting Person: Berge Terence M (VP-Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-30	Common Stock	S	2061	$103.36	Disposed	8851	Direct
2020-11-30	Common Stock	M	3350	$41.93	Acquired	12201	Direct
2020-11-30	Common Stock	S	3350	$103.4022	Disposed	8851	Direct
2020-12-01	Common Stock	S	2939	$103.00	Disposed	5912	Direct
2020-12-01	Common Stock	M	5050	$41.93	Acquired	10962	Direct
2020-12-01	Common Stock	S	5050	$103.00	Disposed	5912	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-30	Options To Purchase Common Stock	$41.93	M	3350	Disposed	2027-03-01	Common Stock (3350)	Direct
2020-12-01	Options To Purchase Common Stock	$41.93	M	5050	Disposed	2027-03-01	Common Stock (5050)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.305 to $103.46. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.26 to $103.51. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.